Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Apr 2010. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
474221000001112 | Ondansetron 4mg orodispersible tablets (Zentiva) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
474241000001119 | Ondansetron 4mg orodispersible tablets (Zentiva) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1515171000001116 | Ondansetron 4mg orodispersible tablets (Zentiva Pharma UK Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1515181000001119 | Ondansetron 4mg orodispersible tablets (Zentiva Pharma UK Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
58707501000001114 | Ondansetron 4mg orodispersible tablets (Bluefish Pharmaceuticals AB) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
58707601000001113 | Ondansetron 4mg orodispersible tablets (Bluefish Pharmaceuticals AB) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
106686101000001119 | Ondansetron 4mg orodispersible tablets (Creo Pharma Ltd) | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ondansetron 4mg orodispersible tablets (Zentiva Pharma UK Ltd) 10 tablet | Has AMP | True | Ondansetron 4mg orodispersible tablets (Zentiva Pharma UK Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets